CASE Letter to Senate Leaders Makes Devastating Case Against Drug Importation Plans
May 11, 2022 Dear Senate Leaders, In spite of well-founded fears about the safety and effectiveness of allowing states to...
May 11, 2022 Dear Senate Leaders, In spite of well-founded fears about the safety and effectiveness of allowing states to...
September 28, 2020 In a move that can only be considered a total disaster for the safety and security...
January 29, 2020 Arlington, VA – Today, CASE Vice President Gerard Scimeca issued the following statement upon the signing of...
Gerard Scimeca – Chairman, CASE January 13, 2020 With the new decade upon us, policymakers should make a New...
December 23, 2019 In what could have been the policy hallmark of his first term in office, President Trump originally...
December 19, 2019 Today, the Food and Drug Administration (FDA) issued a notice of proposed rulemaking to allow the importation...
December 11, 2019 If there is one thing that brings almost all Americans together is our shared disdain for unsolicited...
December 11, 2019 In what could be the policy hallmark of his first term in office, President Trump has...
October 31, 2019 Despite repeated assurances from Nancy Pelosi that her Democratic colleagues are committed to governing in the midst...
Yesterday, the U.S. Department of Health and Human Services released a proposal, outlining two pathways to allow for the importation...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/